Predictions
NeutriSci International Inc
Start price
Target price
Perf. (%)
€0.020
06.05.22
06.05.22
-
06.06.22
06.06.22
33.00%
07.06.22
07.06.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.89
14.05.22
14.05.22
-
14.05.23
14.05.23
-13.51%
28.05.22
28.05.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.79
14.05.22
14.05.22
-
14.05.23
14.05.23
-20.54%
28.05.22
28.05.22
Risky Investment
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€9.52
27.05.21
27.05.21
€32.00
27.05.22
27.05.22
-55.61%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Antibe Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.48
08.07.21
08.07.21
-
08.07.22
08.07.22
-80.56%
21.05.22
21.05.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.45
30.04.22
30.04.22
-
30.04.23
30.04.23
-10.35%
14.05.22
14.05.22
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.00
20.11.21
20.11.21
-
20.11.22
20.11.22
-52.74%
11.05.22
11.05.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.96
06.03.22
06.03.22
-
06.03.23
06.03.23
9.97%
30.04.22
30.04.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.94
06.03.22
06.03.22
-
06.03.23
06.03.23
-0.02%
30.04.22
30.04.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.70
18.04.22
18.04.22
-
18.04.23
18.04.23
-3.95%
30.04.22
30.04.22
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.03
11.11.21
11.11.21
€2.90
11.11.22
11.11.22
-21.78%
28.04.22
28.04.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.71
15.07.21
15.07.21
-
15.07.22
15.07.22
1.92%
23.04.22
23.04.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.15
21.03.22
21.03.22
€4.00
21.03.23
21.03.23
11.30%
04.04.22
04.04.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€7.00
25.03.22
25.03.22
-
25.03.23
25.03.23
-11.25%
02.04.22
02.04.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.15
19.03.22
19.03.22
€0.000
19.03.23
19.03.23
11.30%
02.04.22
02.04.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.96
07.03.22
07.03.22
-
07.03.23
07.03.23
27.52%
28.03.22
28.03.22
Could be worthwhile Investment >10% per year
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
20.02.22
20.02.22
€13.00
20.02.23
20.02.23
-
17.03.22
17.03.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected